Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? (Q35150534)

6 August 2017

1 reference

title

Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? (English)

1 reference

6 August 2017

1 reference

coronary artery disease

1 reference

3

Amir Lerman

1 reference

6 August 2017

Piero O Bonetti

1

1 reference

6 August 2017

David R Holmes

series ordinal

2

1 reference

6 August 2017

Gregory W Barsness

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Journal of the American College of Cardiology

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

11

1 reference

6 August 2017

page(s)

1918-1925

1 reference

Refractory angina pectoris: mechanism and therapeutic options.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Acute hemodynamic effects and angina improvement with enhanced external counterpulsation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Efficacy of enhanced external counterpulsation in the treatment of angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Prior revascularization increases the effectiveness of enhanced external counterpulsation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Psychosocial effects of enhanced external counterpulsation in the angina patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Psychosocial effects of enhanced external counterpulsation in the angina patient: a second study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Treatment benefit in the enhanced external counterpulsation consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Maximizing the hemodynamic benefit of enhanced external counterpulsation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the International EECP Patient Registry (IEPR).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry [IEPR]).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Endothelial dysfunction: does it matter? Is it reversible?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Endothelial dysfunction: a marker of atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Flow-mediated endothelial mechanotransduction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Cardiovascular effects of exercise: role of endothelial shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Nitric oxide regulates local arterial distensibility in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Nitric oxide and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Therapeutic angiogenesis for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Sequenced external counterpulsation and intraaortic balloon pumping in cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Noninvasive revascularization by enhanced external counterpulsation: a case study and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

Do medical devices have enhanced placebo effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900428-5

7 January 2021

10.1016/S0735-1097(03)00428-5

Identifiers

DOI

1 reference

6 August 2017

1 reference